Jacob W. Myerson
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 11
- Surfaces, Coatings and Films top 5%
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
-
- Blood properties and coagulation 7
-
- Blood Coagulation and Thrombosis Mechanisms 7
-
- Lipid Membrane Structure and Behavior 6
- RNA Interference and Gene Delivery 5
-
- Erythrocyte Function and Pathophysiology 5
-
- Protease and Inhibitor Mechanisms 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Alicia M. JacksonFrancesco StellacciVladimir R. MuzykantovSamuel A. WicklineRaisa Y. KiselevaElizabeth D. HoodVladimir V. ShuvaevPatrick M. Glassman
- Journals
- The FASEB Journal (6 papers)Advanced Materials (5 papers)Journal of Cardiovascular Magnetic Resonance (4 papers)
- Partner nations
- United StatesChinaRussia
In The Last Decade
Jacob W. Myerson
51 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Biomaterials 501
- Surfaces, Coatings and Films 135
- Electronic, Optical and Magnetic Materials 309
- Biomedical Engineering 579
- Materials Chemistry 556
Countries citing papers authored by Jacob W. Myerson
This map shows the geographic impact of Jacob W. Myerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob W. Myerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob W. Myerson more than expected).
Fields of papers citing papers by Jacob W. Myerson
This network shows the impact of papers produced by Jacob W. Myerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob W. Myerson. The network helps show where Jacob W. Myerson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jacob W. Myerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 0 | |
| 5 | Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutionsbreakdown → | 2024 | 52 |
| 6 | 2023 | 23 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 2 | |
| 11 | 2019 | 46 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 103 | |
| 14 | 2018 | 52 | |
| 15 | 2017 | 6 | |
| 16 | 2017 | 29 | |
| 17 | 2015 | 64 | |
| 18 | Abstract 15949: Bivalirudin Nanoparticles Enable Simultaneous Detection and Potent Inhibition of Acute Clotting | 2011 | 1 |
| 19 | 2011 | 22 | |
| 20 | 2008 | 76 |
About Jacob W. Myerson
Jacob W. Myerson is a scholar working on Internal Medicine, Biomaterials and Hematology, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Blood properties and coagulation (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Lipid Membrane Structure and Behavior (6 papers), Erythrocyte Function and Pathophysiology (5 papers), RNA Interference and Gene Delivery (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Biomaterials (501 citations), Surfaces, Coatings and Films (135 citations) and Electronic, Optical and Magnetic Materials (309 citations). Jacob W. Myerson has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Alicia M. Jackson, Francesco Stellacci, Vladimir R. Muzykantov, Samuel A. Wickline, Raisa Y. Kiseleva, Elizabeth D. Hood, Vladimir V. Shuvaev, Patrick M. Glassman, Samir Mitragotri and Oscar A. Marcos‐Contreras. Their work appears in journals such as The FASEB Journal, Advanced Materials, Journal of Cardiovascular Magnetic Resonance, Journal of Controlled Release and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.